Published in Infect Immun on May 01, 2004
Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun (2004) 0.98
Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine Development. Front Immunol (2015) 0.88
Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Infect Immun (2006) 0.83
Protective Potential of Antioxidant Enzymes as Vaccines for Schistosomiasis in a Non-Human Primate Model. Front Immunol (2015) 0.83
The redox biology of schistosome parasites and applications for drug development. Curr Pharm Des (2012) 0.83
Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection. Front Immunol (2015) 0.81
Antigen Mimicry between Infectious Agents and Self or Environmental Antigens May Lead to Long-Term Regulation of Inflammation. Front Immunol (2013) 0.78
Functional expression and characterization of a cytosolic copper/zinc-superoxide dismutase of Spirometra erinacei. Parasitol Res (2010) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo (1973) 15.54
The global status of schistosomiasis and its control. Acta Trop (2000) 6.89
The immunobiology of schistosomiasis. Nat Rev Immunol (2002) 6.07
Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature (1991) 3.18
Immunological modulation and evasion by helminth parasites in human populations. Nature (1993) 2.62
Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol (1999) 2.53
Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol (1992) 2.33
Biologically erodable microspheres as potential oral drug delivery systems. Nature (1997) 1.92
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
Improving protein therapeutics with sustained-release formulations. Nat Biotechnol (1998) 1.73
Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine (2003) 1.73
Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst (1995) 1.73
Cell-mediated damage to helminths. Adv Parasitol (1984) 1.64
Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol (1991) 1.61
Immunity to helminths: Ready to tip the biochemical balance? Parasitol Today (1992) 1.60
Superoxide dismutase. Parasitol Today (1994) 1.54
Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng (2001) 1.46
Helminth anti-oxidant enzymes: a protective mechanism against host oxidants? Parasitol Today (1988) 1.44
Schistosomiasis: from risk assessment to control. Trends Parasitol (2002) 1.44
Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis (1993) 1.42
Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 1.24
Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology (2003) 1.22
Class and subclass selection in parasite-specific antibody responses. Trends Parasitol (2003) 1.21
In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity. Cancer Res (2000) 1.20
Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol Today (2000) 1.17
T and B cell epitope mapping of SM23, an integral membrane protein of Schistosoma mansoni. J Immunol (1992) 1.11
Do antioxidants play a role in schistosome host-parasite interactions? Parasitol Today (1998) 1.07
The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans R Soc Trop Med Hyg (1990) 1.06
Controlled release microparticles for vaccine development. Vaccine (1991) 1.06
T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J Immunol (1994) 1.05
Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. Exp Parasitol (1997) 1.04
Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni. Trans R Soc Trop Med Hyg (1995) 1.04
Mechanisms of immune evasion in schistosomiasis. Contrib Microbiol Immunol (1987) 1.02
Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg (2002) 1.01
Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae III. Identification of a mouse strain, P/N, that fails to respond to vaccination. Parasite Immunol (1983) 1.01
Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Parasitol Today (2000) 1.00
Comparison of the cloned genes of the 26- and 28-kilodalton glutathione S-transferases of Schistosoma japonicum and Schistosoma mansoni. Mol Biochem Parasitol (1990) 1.00
Molecular mimicry: parasite evasion and host defense. Curr Top Microbiol Immunol (1989) 0.98
Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. Immunol Invest (1992) 0.97
Schistosomiasis vaccine development: progress and prospects. Mem Inst Oswaldo Cruz (1998) 0.97
Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India. Infect Immun (2000) 0.96
Schistosoma mansoni: levels of antioxidants and resistance to oxidants increase during development. Exp Parasitol (1990) 0.94
CD4+ T cells of schistosomiasis naturally resistant individuals living in an endemic area produce interferon-gamma and tumour necrosis factor-alpha in response to the recombinant 14KDA Schistosoma mansoni fatty acid-binding protein. Scand J Immunol (2000) 0.92
Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals. J Infect Dis (1997) 0.91
Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J Immunol (1993) 0.90
Antioxidant systems in Schistosoma mansoni: evidence for their role in protection of the adult worms against oxidant killing. Int J Parasitol (1988) 0.90
Immunological aspects of human schistosomiasis. Br Med Bull (1998) 0.89
Microparticles and polymers for the mucosal delivery of vaccines. Adv Drug Deliv Rev (1998) 0.89
Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization. Clin Exp Immunol (2000) 0.88
Effector functions of eosinophils in schistosomiasis. Mem Inst Oswaldo Cruz (1992) 0.87
Evidence that cellular immune responses to soluble and membrane associated antigens are independently regulated during human schistosomiasis mansoni. Parasite Immunol (1996) 0.86
Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci (2002) 0.86
Immune responses during human Schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment. J Immunol (1985) 0.86
Immune response to Schistosoma mansoni phosphoglycerate kinase during natural and experimental infection: identification of a schistosome-specific B-cell epitope. Infect Immun (1995) 0.85
Expression and characterization of glutathione peroxidase activity in the human blood fluke Schistosoma mansoni. Infect Immun (1996) 0.85
Schistosoma mansoni: cloning of a complementary DNA encoding a cytosolic Cu/Zn superoxide dismutase and high-yield expression of the enzymatically active gene product in Escherichia coli. Exp Parasitol (1992) 0.85
Serological differences between acute and chronic schistosomiasis mansoni detected by enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg (1979) 0.84
Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres. Vaccine (2002) 0.82
Immune effector role of macrophages in experimental schistosomiasis mansoni. Immunol Ser (1994) 0.82
Differences in immunogenicity and vaccine potential of peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase. Vaccine (2003) 0.82
Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model. Cancer Immunol Immunother (1998) 0.80
Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni. Am J Trop Med Hyg (1994) 0.78
Molecular and serological characteristics of the glutathione S-transferases of Schistosoma japonicum and Schistosoma mansoni. Parasite Immunol (1988) 0.78
Pulmonary granulomatous hypersensitivity: cell-mediated responses to embolized schistosome larvae and eggs. Reg Immunol (1993) 0.76
Schistosome vaccines. Experientia (1991) 0.76
The genome of the blood fluke Schistosoma mansoni. Nature (2009) 5.94
Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science (2007) 4.89
Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med (2006) 2.59
snoRNA, a novel precursor of microRNA in Giardia lamblia. PLoS Pathog (2008) 2.36
A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl Trop Dis (2012) 2.32
Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum Pathol (2007) 1.84
The involvement of two cdc2-related kinases (CRKs) in Trypanosoma brucei cell cycle regulation and the distinctive stage-specific phenotypes caused by CRK3 depletion. J Biol Chem (2004) 1.75
Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol (2006) 1.69
IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J Immunol (2007) 1.67
New policies for using anthelmintics in high risk groups. Trends Parasitol (2002) 1.63
Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop Med Int Health (2006) 1.61
Enhancement of adaptive immunity to Neisseria gonorrhoeae by local intravaginal administration of microencapsulated interleukin 12. J Infect Dis (2013) 1.53
Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol (2003) 1.46
Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J (2005) 1.44
Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans R Soc Trop Med Hyg (2006) 1.40
QNI seek clarity over the future of the specialist practitioner role. Br J Community Nurs (2008) 1.39
Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors. J Immunol (2006) 1.37
A research agenda for helminth diseases of humans: social ecology, environmental determinants, and health systems. PLoS Negl Trop Dis (2012) 1.33
An aurora kinase homologue is involved in regulating both mitosis and cytokinesis in Trypanosoma brucei. J Biol Chem (2006) 1.31
Genomic linkage map of the human blood fluke Schistosoma mansoni. Genome Biol (2009) 1.30
Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene. PLoS Pathog (2006) 1.29
A PHO80-like cyclin and a B-type cyclin control the cell cycle of the procyclic form of Trypanosoma brucei. J Biol Chem (2003) 1.28
Identification of a novel chromosomal passenger complex and its unique localization during cytokinesis in Trypanosoma brucei. PLoS One (2008) 1.26
Centrin1 is required for organelle segregation and cytokinesis in Trypanosoma brucei. Mol Biol Cell (2007) 1.25
Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin. Infect Immun (2003) 1.25
Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials (2007) 1.23
Human helminth co-infection: analysis of spatial patterns and risk factors in a Brazilian community. PLoS Negl Trop Dis (2008) 1.23
Tousled-like kinase in a microbial eukaryote regulates spindle assembly and S-phase progression by interacting with Aurora kinase and chromatin assembly factors. J Cell Sci (2007) 1.17
Socioeconomic determinants of schistosomiasis in a poor rural area in Brazil. Acta Trop (2006) 1.15
Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity. Cancer Res (2009) 1.13
Functional characterization of the 11 non-ATPase subunit proteins in the trypanosome 19 S proteasomal regulatory complex. J Biol Chem (2002) 1.11
The chromosomal passenger complex and a mitotic kinesin interact with the Tousled-like kinase in trypanosomes to regulate mitosis and cytokinesis. PLoS One (2008) 1.10
Capped mRNA with a single nucleotide leader is optimally translated in a primitive eukaryote, Giardia lamblia. J Biol Chem (2004) 1.10
Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention. Exp Parasitol (2003) 1.10
Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl Trop Dis (2011) 1.10
Pairwise knockdowns of cdc2-related kinases (CRKs) in Trypanosoma brucei identified the CRKs for G1/S and G2/M transitions and demonstrated distinctive cytokinetic regulations between two developmental stages of the organism. Eukaryot Cell (2005) 1.09
Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains. BMC Evol Biol (2007) 1.08
Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun (2005) 1.07
Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites. Science (2013) 1.07
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol (2012) 1.05
Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunol Invest (2012) 1.05
An easily dissociated 26 S proteasome catalyzes an essential ubiquitin-mediated protein degradation pathway in Trypanosoma brucei. J Biol Chem (2002) 1.05
Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity. J Immunol (2009) 1.04
Coupling of posterior cytoskeletal morphogenesis to the G1/S transition in the Trypanosoma brucei cell cycle. Mol Biol Cell (2004) 1.03
Identification of a bacterial-like HslVU protease in the mitochondria of Trypanosoma brucei and its role in mitochondrial DNA replication. PLoS Pathog (2008) 1.03
SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions. Front Biosci (2002) 1.01
Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci (2007) 1.00
KMP-11, a basal body and flagellar protein, is required for cell division in Trypanosoma brucei. Eukaryot Cell (2008) 1.00
Short report: quantification of leishmaniavirus RNA in clinical samples and its possible role in pathogenesis. Am J Trop Med Hyg (2003) 1.00
Novel scaffolds fabricated from protein-loaded microspheres for tissue engineering. Biomaterials (2007) 0.99
Mapping of the complement C9 binding domain in paramyosin of the blood fluke Schistosoma mansoni. Int J Parasitol (2006) 0.98
Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage. Infect Immun (2004) 0.98
Efficient genotyping of Schistosoma mansoni miracidia following whole genome amplification. Mol Biochem Parasitol (2009) 0.98
Differentiation of Trypanosoma brucei may be stage non-specific and does not require progression of cell cycle. Mol Microbiol (2003) 0.97
Exposure to Schistosoma mansoni infection in a rural area in Brazil. Part III: household aggregation of water-contact behaviour. Trop Med Int Health (2004) 0.97
Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis. J Immunol (2009) 0.97
Advances in schistosome genomics. Trends Parasitol (2004) 0.97
Chemokine receptor expression on the surface of peripheral blood mononuclear cells in Chagas disease. J Infect Dis (2004) 0.96
A multihousehold study reveals a positive correlation between age, severity of ocular toxoplasmosis, and levels of glycoinositolphospholipid-specific immunoglobulin A. J Infect Dis (2004) 0.96
Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev (2013) 0.96
Profile of central and effector memory T cells in the progression of chronic human chagas disease. PLoS Negl Trop Dis (2009) 0.96
Human helminth co-infection: no evidence of common genetic control of hookworm and Schistosoma mansoni infection intensity in a Brazilian community. Int J Parasitol (2009) 0.95
Okadaic acid overcomes the blocked cell cycle caused by depleting Cdc2-related kinases in Trypanosoma brucei. Exp Cell Res (2006) 0.95
Health education through analogies: preparation of a community for clinical trials of a vaccine against hookworm in an endemic area of Brazil. PLoS Negl Trop Dis (2010) 0.95
Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells. J Immunol (2005) 0.95
Differential impact of metacyclic and blood trypomastigotes on parasitological, serological and phenotypic features triggered during acute Trypanosoma cruzi infection in dogs. Acta Trop (2007) 0.94
Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation. J Biol Chem (2003) 0.94
The role of population movement in the epidemiology and control of schistosomiasis in Brazil: a preliminary typology of population movement. Mem Inst Oswaldo Cruz (2010) 0.94
Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs. Vaccine (2013) 0.94
Research priorities for neglected infectious diseases in Latin America and the Caribbean region. PLoS Negl Trop Dis (2010) 0.94
Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection. PLoS Negl Trop Dis (2010) 0.94
Polo-like kinase guides cytokinesis in Trypanosoma brucei through an indirect means. Eukaryot Cell (2010) 0.93
Human schistosomiasis mansoni: intensity of infection differentially affects the production of interleukin-10, interferon-gamma and interleukin-13 by soluble egg antigen or adult worm antigen stimulated cultures. Trans R Soc Trop Med Hyg (2004) 0.93
Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni. BMC Evol Biol (2007) 0.93
Induction of CD4(+)CD25(+)FOXP3(+) regulatory T cells during human hookworm infection modulates antigen-mediated lymphocyte proliferation. PLoS Negl Trop Dis (2011) 0.93
Depletion of anaphase-promoting complex or cyclosome (APC/C) subunit homolog APC1 or CDC27 of Trypanosoma brucei arrests the procyclic form in metaphase but the bloodstream form in anaphase. J Biol Chem (2005) 0.93
Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem Inst Oswaldo Cruz (2009) 0.93
Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity. J Immunol (2011) 0.92
Inhibition and structure of Trichomonas vaginalis purine nucleoside phosphorylase with picomolar transition state analogues. Biochemistry (2007) 0.92
A microRNA derived from an apparent canonical biogenesis pathway regulates variant surface protein gene expression in Giardia lamblia. RNA (2011) 0.92
Production of calcium-mobilizing metabolites by a novel member of the ADP-ribosyl cyclase family expressed in Schistosoma mansoni. Biochemistry (2005) 0.92
Polo-like kinase is expressed in S/G2/M phase and associated with the flagellum attachment zone in both procyclic and bloodstream forms of Trypanosoma brucei. Eukaryot Cell (2008) 0.92
Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. J Infect Dis (2002) 0.91
Identification and characterization of a nuclear receptor subfamily I member in the Platyhelminth Schistosoma mansoni (SmNR1). FEBS J (2006) 0.91
Gene regulation in Giardia lambia involves a putative microRNA derived from a small nucleolar RNA. PLoS Negl Trop Dis (2011) 0.91
Cytological and biochemical evidence for a gonad-preferential interplay of SmFKBP12 and SmTbetaR-I in Schistosoma mansoni. Mol Biochem Parasitol (2004) 0.91
A potent trypanocidal component from the fungus Lentinus strigosus inhibits trypanothione reductase and modulates PBMC proliferation. Mem Inst Oswaldo Cruz (2008) 0.91
Necator americanus and helminth co-infections: further down-modulation of hookworm-specific type 1 immune responses. PLoS Negl Trop Dis (2011) 0.90
The profile of snoRNA-derived microRNAs that regulate expression of variant surface proteins in Giardia lamblia. Cell Microbiol (2012) 0.90
Schistosoma mansoni: SmE78, a nuclear receptor orthologue of Drosophila ecdysone-induced protein 78. Exp Parasitol (2008) 0.90
Matrix metalloproteinases 2 and 9 are differentially expressed in patients with indeterminate and cardiac clinical forms of Chagas disease. Infect Immun (2013) 0.90
Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-gamma. J Immunol (2003) 0.90
Enhancing the oral bioavailability of the poorly soluble drug dicumarol with a bioadhesive polymer. J Pharm Sci (2003) 0.89